Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
Open Access
- 15 May 2017
- journal article
- review article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 1 (7), 816-835
- https://doi.org/10.1210/js.2017-00092
Abstract
Nicotinamide adenine dinucleotide (NAD+) is an established cofactor for enzymes serving cellular metabolic reactions. More recent research identified NAD+ as a signaling molecule and substrate for sirtuins and poly-adenosine 5′-diphosphate polymerases; enzymes that regulate protein deacetylation and DNA repair, and translate changes in energy status into metabolic adaptations. Deranged NAD+ homeostasis and concurrent alterations in mitochondrial function are intrinsic in metabolic disorders, such as type 2 diabetes, nonalcoholic fatty liver, and age-related diseases. Contemporary NAD+ precursors show promise as nutraceuticals to restore target tissue NAD+ and have demonstrated the ability to improve mitochondrial function and sirtuin-dependent signaling. This review discusses the accumulating evidence for targeting NAD+ metabolism in metabolic disease, maps the different strategies for NAD+ boosting, and addresses the challenges and open questions in the field. The health potential of targeting NAD+ homeostasis will inform clinical study design to identify nutraceutical approaches for combating metabolic disease and the unwanted effects of aging.Keywords
This publication has 164 references indexed in Scilit:
- Sirtuin Deacetylases as Therapeutic Targets in the Nervous SystemNeurotherapeutics, 2013
- PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 ActivationCell Metabolism, 2011
- Inflammatory markers in population studies of agingAgeing Research Reviews, 2010
- Discovery of a Proneurogenic, Neuroprotective ChemicalCell, 2010
- Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individualsDiabetologia, 2010
- Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal MuscleCell Metabolism, 2010
- Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and InflammationCell Metabolism, 2009
- The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian ControlCell, 2008
- SIRT1 Regulates Circadian Clock Gene Expression through PER2 DeacetylationCell, 2008
- Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic EnzymeCell Metabolism, 2007